GE HealthCare Unveils Logiq Totus Ultrasound at ECR
Designed for full-body imaging, the new modality reportedly offers a lightweight portable design, AI-powered tools and enhanced high-resolution images.
Emphasizing a combination of workflow enhancements and advances to facilitate improved image quality, GE HealthCare has launched the Logiq Totus ultrasound system at the European Congress of Radiology.
Use of the Logiq Totus ultrasound system enables access to a wide range of transducers to help foster high resolution for a variety of areas, advanced tools such as 2D Shear Wave Elastography and access to cSound™ Architecture, which provides enhanced consistent image quality, according to GE HealthCare.
GE HealthCare said the Logiq Totus ultrasound system, launched at the European Congress of Radiology, offers a combination of workflow enhancements and advances to facilitate improved image quality. (Image courtesy of GE HealthCare.)
The company said other advantages with the lightweight, portable system include tools such as Scan Assistant and Voice Control that help streamline workflows, and access to Breast and Thyroid Assistant artificial intelligence (AI) support tools from Koios Medical.
“ … We’re focused on driving innovation that enables precision care, and the enhanced (Logiq) portfolio allows us to deliver on this promise with products and solutions that help clinicians optimize care with ease and efficiency,” said Jyoti Gera, the general manager of General Imaging and Primary Care, Ultrasound at GE HealthCare.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
